SYS-CON MEDIA Authors: Kevin Benedict, Gilad Parann-Nissany, Michael Bushong, Eric Brown

News Feed Item

Pharm-Bio Building Boom: More Than $20 Billion Set for 2014 North American Capital Project Starts, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwired) -- 01/17/14 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- It would be a hard to say just what the true health of the economy is today, with so many conflicting reports. With the general financial forecast still gyrating between growth and despair, it is gratifying to offer some positive news from the Pharmaceutical-Biotech Industry. According to a recent analysis of Industrial Info's Pharmaceutical Tracker - Online Database, a projected $20.8 billion in active reported projects are scheduled to begin construction in 2014, allocated among 720 active capital and maintenance, repair and operations (MRO) projects.

Other companies featured: AECOM (NYSE:ACM), Bristol-Myers Squibb (NYSE:BMY)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/news/abstract.jsp?newsitemID=240300&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and nine international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle¬ô, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Joe Govreau
713-783-5147

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.